Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808090 · ClinicalTrials.gov registry record · NA
Obesity and Endogenous Oxalate Synthesis
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT03808090 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 58 participants.
The verdict
NCT03808090, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The goal of this study is to determine if obesity is associated with increased endogenous oxalate synthesis as assessed by urinary oxalate excretion, which is a known risk factor for calcium oxalate kidney stones. The study will recruit adult participants without history of kidney stones. Participants will * Ingest fixed diets containing low amounts of oxalate for 4 days * Collect 24-hr urine samples during the fixed diet
Interventions
- DIETARY_SUPPLEMENT Normal Individuals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03808090
The ClinicalTrials.gov registry entry for NCT03808090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Normal Individuals is the first listed.
NCT03808090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03808090 about?
NCT03808090 is a clinical study titled "Obesity and Endogenous Oxalate Synthesis". The goal of this study is to determine if obesity is associated with increased endogenous oxalate synthesis as assessed by urinary oxalate excretion, which is a known risk factor for calcium oxalate kidney stones. The study will recruit adult participants without history of kidney stones. Participa...
What is the current status of trial NCT03808090?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2013-01-01. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03808090?
The interventions under investigation include: Normal Individuals (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03808090?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.